The programme enables existing regulatory affairs personnel in the pharmaceutical regulatory industry to understand all current diagnostic and medical device regulations and develop the necessary skills to work successfully in the dynamic world of regulatory affairs.

What will I be able to do when I finish this programme?

On completion of this programme, students should be able to:

Devise and implement global strategies for drug, biologic, and device development and evaluation;
Apply principles of basic and applied pharmaceutical sciences in drug and biologics discovery and development.

What subjects will I study?

Lifecycle Management, Vigilance, Surveillance and Risk management
Pharmaceutical Technology Regulatory Affairs
Non Clinical and Clinical Evaluation of Pharmaceutical Technologies
Principles of Discovery of Medicines and Development Planning
Research Methods and Technical Report Writing
Special Populations and Biologicals and Advanced Therapies
Dissertation

Special Features of this programme

The primary objective of this Masters is to enable learners to expand their job responsibilities and opportunities in new areas after completing the programme. It will also enable learners to create an excellent network within the pharmaceutical industry, both by meeting other regulatory professionals during the course and by interacting with industry experts while completing their dissertation research.

Study & Career Opportunities

Opportunities for graduates from this programme include progression to Level 10 (PhD) programmes in related fields of study.

More than 85 pharmaceutical companies (including nine of the top 10) operate over 100 facilities in Ireland. The industry exports around $85 billion worth of products each year and is now one of the largest exporters of pharmaceuticals in the world. This programme is designed to meet the growing demand for scientists to service the current and emerging biotechnology-based industries in Ireland in particular, the South-East, Mid-East and Midlands.